Unlisted Deals:
ador powertron 500.00 (4,900.00 %) amol minechem 601.00 (0.17 %) anglo french drugs 950.00 (2.15 %) anugraha valve 510.00 (0.99 %) apl metals 39.00 (-2.50 %) apollo fashion 92.00 (-4.17 %) arkfin investments 50.00 arohan 250.00 (-1.96 %) assam carbon 325.00 (4.84 %) avalokiteshvar 242.00 (0.83 %) axles india 680.00 (0.74 %) balmer lawrie 200.00 (-0.99 %) bharat hotels 385.00 (-2.53 %) bima mandi 235.00 (-2.08 %) bira 545.00 (-0.91 %) blsx limited 35.00 (2.94 %) boat 1,550.00 (-1.90 %) c & s electric 1,070.00 (1.90 %) cable corporation 16.00 (-5.88 %) capgemini 14,300.00 (-1.38 %) care health 184.00 (-0.54 %) carrier aircon 550.00 (0.92 %) cial 465.00 (-1.06 %) csk 195.00 (-1.52 %) dalmia refract 270.00 (-1.82 %) dfm foods 470.00 (0.64 %) dsp merrill lynch 1,000.00 east india pharma 39.00 (-2.50 %) eaton fluid 445.00 (1.14 %) electronica plastic 4,500.00 (2.27 %) elgi ultra 400.00 elofic industries 2,850.00 (1.79 %) esl steel 42.00 (-2.33 %) fincare business 87.00 (1.16 %) fincare sfbl 205.00 (1.49 %) finopaytech limited 149.00 (-0.67 %) flipkart india 231,001.00 (0.00 %) frick india 3,400.00 (-2.86 %) gkn driveline 1,750.00 (2.94 %) goodluck defence 288.00 (-0.69 %) group pharma 300.00 gynofem healthcare 70.00 (7.69 %) hazira cargo terminals limited 205.00 (1.49 %) hdb financial 1,220.00 (-0.41 %) hdfc ergo 370.00 (1.70 %) hdfc securities 10,800.00 (-1.81 %) hella india 900.00 (-2.17 %) hero fincorp 1,950.00 (-0.76 %) hexaware 980.00 (-0.51 %) hicks 1,650.00 (3.13 %) hira ferro 200.00 (2.56 %) honeywell electrical 7,500.00 (2.74 %) ikf finance 320.00 (-3.03 %) incred financial 10.00 (1.01 %) incred holdings 153.00 (-1.29 %) india carbon 1,120.00 (-1.32 %) india exposition 121.00 (0.83 %) indian potash 3,100.00 (-1.59 %) indian seamless 195.00 (2.63 %) indo alusys 25.75 (-0.96 %) indofil 1,430.00 (-0.69 %) infinite computer 405.00 (1.25 %) inkel 22.00 (-2.22 %) jana small finance bank 75.00 kel 525.00 (-1.87 %) kial 137.00 (-0.72 %) klm axiva 15.50 (3.33 %) kurlon limited 1,275.00 (1.59 %) lava 43.00 (-4.44 %) mahindra rural mrhfl 100.00 manipal housing 74.00 (2.07 %) manjushree technopack 850.00 (-2.86 %) martin & harris 820.00 (-1.20 %) matrix gas 810.00 (-2.41 %) merino 3,250.00 (-1.52 %) minosha 282.00 (0.71 %) mitsubishi heavy 207.00 (-0.48 %) mkcl 425.00 (-2.30 %) mobikwik 640.00 (-1.54 %) mohan meakin 2,300.00 (-4.17 %) mohfl 15.00 (7.14 %) msei 2.50 (11.11 %) msil 34.00 (3.03 %) nayara energy 760.00 (2.01 %) nayara energy ncd 320.00 (1.59 %) ncdex 198.00 (-1.00 %) ncl buildtek 310.00 (-3.13 %) ncl holdings 106.00 (0.95 %) nsdl 1,000.00 (-0.99 %) nse india 1,800.00 (-2.70 %) onix renewable 21,000.00 (2.44 %) orbis financial 399.00 (-0.25 %) oswal minerals 60.10 (-1.48 %) otis elevator 4,100.00 (2.50 %) oyo rooms 53.00 (-1.85 %) panasonic appliances 262.00 (0.77 %) paymate india 500.00 (-1.96 %) pharmeasy 8.60 (1.78 %) pharmed limited 660.00 (3.13 %) philips domestic 625.00 (-2.34 %) philips india 925.00 (-0.54 %) pnb metlife 70.00 proyuga adtech 25.00 purity flexpack 20.00 ramaraju surgical 260.00 (-1.89 %) rapido 16,650.00 (0.03 %) rasoi 82,000.00 (2.50 %) reliance gic 500.00 (2.04 %) resins plastics 550.00 (4.76 %) ring plus aqua 560.00 (1.82 %) rrp s4e innovation 295.00 (-1.67 %) sab miller 535.00 (0.94 %) sbi amc 2,650.00 (-1.12 %) sbi general insurance 621.00 (0.16 %) scottish assam 505.00 (1.00 %) shriram life 261.00 (0.38 %) sigachi laboratories 36.00 (-2.70 %) signify 1,325.00 (-1.85 %) smile microfinance 51.00 (-1.92 %) sterlite grid 5 255.00 (-7.27 %) sterlite power 570.00 (-3.39 %) studds 1,460.00 (-0.68 %) svsml 315.00 (2.94 %) t stanes 800.00 (1.27 %) tata capital 885.00 (-0.56 %) trl krosaki 1,750.00 (-1.41 %) urban tots 64.00 (-1.54 %) utkarsh coreinvest 290.00 (-1.69 %) vikram solar 442.00 (-0.67 %) vivriti capital 1,040.00 (-0.95 %)
×

Martin & Harris Unlisted Share Price

Martin & Harris Company Fundamentals

Company Name
Martin And Harris Laboratories Limited
Scrip Name
Martin & Harris
Last Traded Price
820.00
-1.20 %
No. of Outstanding Shares
3,996,040
PAN No.
AABCM0832A
Face Value
10
EPS
101.17
PE ratio
8.11
P/S Ratio
1.82
Market Capitalization
327.68 Crore
Book value
1581.74
P/BV
0.52
52 Week High
1,030.00 (15/04/24)
52 Week Low
820.00 (20/11/24)
Lifetime High
2,800.00 (09/01/22)
Lifetime Low
205.00 (31/05/19)
Day High
820.00
Day Low
820.00
ISIN No.
INE03VV01015
Available on
nsdl
ROFR Require
No
Sector
Pharma
CIN
U24239HR1993PLC033630
Registration Date
22/07/1993

Martin & Harris Share Price Performance

Martin and Harris Laboratories Limited Unlisted Share – Company Overview

MARTIN AND HARRIS LABORATORIES LIMITED was first established in 1996 and is based in Gurgaon, Haryana. The company is a part of Apeejay Group, which is India’s oldest and largest Conglomerates. Apeejay Group is a leading Industrial & Investment house with businesses in Automotive, Chemicals & Plastics, Distribution, Logistics & Retail, Pharmaceuticals & life sciences, real estate, and international trading and a nascent presence in IT, merchant banking & financial services and publishing.

Martin and Harris Laboratories Limited is primarily engaged in the business of manufacturing pharmaceuticals, medicinal chemicals & botanical products. The company intensively focuses on drugs used for Hyper Tension, High blood pressure, and heart attack. Apart from its primary business, the company also undertakes fund management through investment in different avenues like mutual funds, equity, etc.

Martin and Harris Laboratories Limited has two units located at Roorkee, Uttarakhand, and Una in Himachal Pradesh. The company is continuously striving to expand its manufacturing facilities and meet global standards.

The company was awarded ‘Best Pharma Excellence awards’ in 2018 by ASSOCHAM India.

MARTIN & HARRIS Share Price, Share Details as of March 31, 2024

 

MARTIN & HARRIS Outstanding Shares:

 

3996040

Face Value of MARTIN & HARRIS Share

Rs. 10/- Per Equity Share

ISIN of MARTIN & HARRIS Share

 

 

INE03VV01015

Lot Size of MARTIN & HARRIS Share

 

 

100

MARTIN & HARRIS Share Price

Best In Industry

PAN Number of MARTIN & HARRIS

 

 

AABCM0832A

 

GST Number of MARTIN & HARRIS

06AABCM0832A2Z8

Martin And Harris Laboratories Limited Incorporation Details

CIN of Martin and Harris Laboratories

U24239HR1993PLC033630

Registration Date of Martin and Harris Laboratories

22 July 1993

Category/Sub-category of Martin and Harris Laboratories

Company Limited by Shares

Martin and Harris Laboratories Registered office address 

NH-8, Delhi Jaipur Highway,

Village, Pachgaon (Fazalwas),

District Gurgaon, Haryana

Martin and Harris Laboratories Registrar and Transfer Agent address and contact details

NA

Martin And Harris Laboratories Limited Principal Business Activities

Name and Description of main products/services

NIC Code of the product/service

% to total turnover of the Company

Manufacture of Pharmaceutical, Medicinal Chemical & Botanical Products

210

52.03%

Fund management activities

663

47.97%

Martin And Harris Laboratories Limited Board of Directors

MR. S. L. LAAD

MR. Nasim Uddin

MR. Vivek Manohar Padgaonkar

MR. H. S. THAKUR

MR. Ashok Chandra Sen

Martin And Harris Laboratories Particular of Subsidiary Companies

Name of the Company

% of shares held

Delite Infrastructure Private limited

100.00%

Industry Outlook

 Indian Pharmaceutical market ranks as 3rd largest in the world in terms of volume and 14th largest in terms of value. Healthcare has become one of the largest sectors of the Indian economy, in terms of both employment and revenue. India is known as the Pharmacy of the world and is the largest provider of generic drugs at a global level. The pharmaceutical industry of India supplies over 50% of the global demand for various vaccines, 40% of generic demands in the USA, and 25% of all the medicines in the United Kingdom. Excellent Research & Development, low cost of labor, availability of management and technical personnel, and local equipment’s availability has helped India to manufacture pharma products at a very low cost.

The Indian healthcare market may see a 3 fold jump in terms of value to reach US$ 372 billion by FY 2022. The growth can be attributed to rising income, greater health awareness, increased precedence of lifestyle disease, and Indian prominence in making medicinal products for the treatment of COVID 19. India aims to achieve vaccination for COVID-19 of 30 Crore people in the next few months.

Export of Pharmaceuticals products from India stood at US$ 16.8 billion in FY 2020 and US$ 2.07 billion in the month of October 2020. In the first 3 quarters of FY 2021, India exported pharmaceuticals worth US$ 15.86 billion. India supplied around 45 tons and 400 million tablets of hydroxychloroquine to around 114 countries globally to treat the covid patients in the initial stage of the covid-19 pandemic. Exports in FY 2021 of Indian pharma products are expected to cross US$ 24 billion, increasing by over 16% when compared to FY 2020.

After the onset of COVID 19, the Indian pharmaceutical sector became the busiest sector in the Indian economy. The pandemic proved to be a boon in disguise for the Indian pharmaceutical sector.

Martin & Harris Annual Reports

Martin And Harris Annual Report 2019-20

Download

Martin & Harris Annual Report 2023-2024

Download

Martin & Harris Annual Report 2021-2022

Download

Recent News

Wealth Wisdom - WWIPL
Support Megha Support Neha

News Alert